Immuse
  • English
    • English
    • Chinese
    • IMMUSE LC-Plasma for Taiwan
For Manufacturers
Menu
Contact
  • English
    • English
    • Chinese
    • IMMUSE LC-Plasma for Taiwan
For Manufacturers
  • About IMMUSE®
    • Immune System 101
    • What is a Postbiotic?
    • Consumer FAQs
  • Benefits
    • Immune Support
    • Sports Nutrition Support
    • Productivity Support
  • Science & Research
    • Vital Role of pDCs
  • Where to Find
  • News & Blog
    • Blog
  • Contact Us

IMMUSE® News

  • AMABIE™ Launches Sparkling Tonic Inspired by Japanese Legend and Powered by Postbiotic IMMUSE®

    02 December 2024

    AMABIE™, a functional beverage from Step Change Innovations, recently launched its new Sparkling Immunity Tonic inspired by the legendary Japanese sea creature Amabie, known for bringing wellness and abundance in a time of need. Read More ›

  • NO CAP! Soda Pop Offers The First Healthier Alternative To Soda In The US With Novel Postbiotic IMMUSE®

    12 September 2024

    The beverage world recently learned about NO CAP! Soda Pop, a revolutionary better-for-you soda that launched in the US market. Infused with Kyowa Hakko USA, Inc.'s IMMUSE®. Read More ›

  • Introducing Bobelo's Postbiotic Immunity with IMMUSE™ for the Whole Family

    25 April 2024

    Kyowa Hakko U.S.A., Inc. and Bobelo have partnered to launch the all-new Postbiotic Immunity, a self-carbonating hydration drink that delivers comprehensive immune support. Read More ›

  • Kyowa Hakko USA Launches First Supplement Containing IMMUSE™ in Mexico

    12 September 2023 PRWeb.com

    Kyowa Hakko USA is expanding the global reach of its IMMUSE™ postbiotic with its inaugural product launch in Mexico with the pharmaceutical manufacturer Quifaest. Read More ›

    immune health
  • Kyowa Hakko’s IMMUSE™ Postbiotic Wins Inaugural “Microbiome Modulation” Industry Award

    14 July 2023 PRWEB

    Kyowa Hakko USA is thrilled to announce that our groundbreaking product, IMMUSE™ postbiotic for immune health, has been honored as the inaugural recipient of the the Ingredient of the Year: Microbiome Modulation category in the esteemed annual awards by NutraIngredients-USA. Read More ›

    immune health, awards
  • Well Traveled Releases a Novel Travel Supplement Featuring IMMUSE™

    12 April 2023 PRWeb.com

    Kyowa Hakko’s IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, “Well Traveled Immune Activator." Read More ›

  • Comple.med Launches the First Food Supplement in Europe Featuring IMMUSE®

    01 February 2023 MILAN, ITALY

    Kyowa Hakko’s IMMUSE®, a clinically researched unique postbiotic, provides immune support in Lactoflor® Immuno 200 . Read More ›

  • Kyowa Hakko Announces Glaxon’s Limited-Time Offer Becomes A Permanent Feature

    26 October 2022

    After a resoundingly successful limited-time offering, Glaxon™ has now added Kyowa Hakko’s IMMUSE™ to all SuperGreens Immune formulas. Read More ›

    immune health, functional foods, postbiotics, SuperGreens
  • Kyowa Hakko USA Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™

    19 May 2022 PRWeb.com

    With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP. Read More ›

  • Kyowa Hakko USA Announces the Appointment of Dr. Heather Moday as an Educational Partner for IMMUSE™ LC-Plasma

    12 May 2022 PRWeb.com

    With a special interest in immune system dysfunction, including autoimmunity, allergy, and the stress-immune connection, Dr. Moday puts IMMUSE™, an award-winning postbiotic, at the forefront of ingredients to look out for in nutritional supplements. Read More ›

  • 1
  • 2
  • Next →

Interested in IMMUSE? Subscribe to updates.

Subscribe to updates Subscribe for updates
Find Products
Find Products Find products that contain IMMUSE
Find Products Find products that contain IMMUSE
Kirin logo      Kyowa logo
Home | Get News Alerts | News | Where to Find | Privacy Policy | Kyowa Hakko USA | Kyowa Hakko Bio | Kirin Holdings | Contact Us | Kyowa Partner Toolkit

IMMUSE® is a clinically researched lactic acid bacteria developed by Kirin Holdings Co., Ltd.

Copyright © 2010-2025 by All Rights Reserved.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.